First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1199-1203

  Kim, Tae Min ^a,b   Kim, Ki Hwan ^a,b   Lee, Min Joung ^a   Jeon, Yoon Kyung ^a,b   Lee, Se Hoon ^a,b   Kim, Dong Wan ^a,b   Kim, Chul Woo ^a,b   Kim, Il Han ^a,b   Khwarg, Sang In ^a   Heo, Dae Seog ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXYCYCLINE; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENATURATION; DRUG EFFICACY; FOLLOW UP; HUMAN; KOREA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUTROPHIL COUNT; NEUTROPHILIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR ADNEXAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; EYE NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 77953197341     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01502.x     Document Type: Article

References (27)

1. Moslehi R, Devesa SS, Schairer C, Fraumeni JF. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst 2006, 98:936-9.
2. Oh DE, Kim YD. Lymphoproliferative diseases of the ocular adnexa in Korea. Arch Ophthalmol 2007, 125:1668-73.
3. Ferreri AJ, Dolcetti R, Du MQ. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 2008, 19:835-46.
4. Rosado MF, Byrne GE, Ding F. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006, 107:467-72.
5. Chanudet E, Zhou Y, Bacon CM. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006, 209:344-51.
6. Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer 2007, 110:809-15.
7. Ferreri AJ, Guidoboni M, Ponzoni M. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004, 96:586-94.
8. Ferreri AJ, Ponzoni M, Guidoboni M. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005, 23:5067-73.
9. Ferreri AJ, Ponzoni M, Guidoboni M. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst 2006, 98:1375-82.
10. Ferreri AJ, Dognini GP, Ponzoni M. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma. Ann Oncol 2008, 19:194-5.
11. Yoo C, Ryu MH, Huh J. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Am J Hematol 2007, 82:821-3.
12. Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 2006, 108:1451-60.
13. Harris NL, Jaffe ES, Diebold J. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999, 17:3835-49.
14. Madico G, Quinn TC, Boman J, Gaydos CA. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol 2000, 38:1085-93.
15. Cheson BD, Horning SJ, Coiffier B. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999, 17:1244.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-81.
17. Song EK, Kim SY, Kim TM. Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Ann Oncol 2008, 19:242-6.
18. Paesmans M, Sculier JP, Libert P. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 1995, 13:1221-30.
19. Negrier S, Escudier B, Gomez F. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol 2002, 13:1460-8.
20. Schmidt H, Suciu S, Punt CJ. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 2007, 25:1562-9.
21. Neal CP, Mann CD, Sutton CD. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Eur J Cancer 2009, 45:56-64.
22. Siddiqui M, Ristow K, Markovic SN. Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol 2006, 134:596-601.
23. Kim DH, Baek JH, Chae YS. Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 2007, 21:2227-30.
24. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev 2004, 4:644-53.
25. Ponzoni M, Ferreri AJ, Guidoboni M. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res 2008, 14:5794-800.
26. van Zandbergen G, Gieffers J, Kothe H. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 2004, 172:1768-76.
27. Grunberger B, Hauff W, Lukas J. 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol 2006, 17:484-7.